Fighting back

Peptidomimetics as a new weapon in the battle against antibiotic resistance

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The discovery, development, and clinical exploitation of antibiotics with new mechanisms of action is a top priority in the battle against untreatable infectious diseases. Peptidomimetics can successfully control infections caused by multidrug-resistant pathogens. This Perspective discusses fi ndings in a recent Science paper on a member of this class of therapeutic agents that targets bacterial outer-membrane synthesis.

Original languageEnglish
JournalScience Translational Medicine
Volume2
Issue number21
DOIs
Publication statusPublished - 2010

Fingerprint

Peptidomimetics
Weapons
Infection Control
Microbial Drug Resistance
Communicable Diseases
Anti-Bacterial Agents
Membranes
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{4c4c1f53394644528e97e4aa24593842,
title = "Fighting back: Peptidomimetics as a new weapon in the battle against antibiotic resistance",
abstract = "The discovery, development, and clinical exploitation of antibiotics with new mechanisms of action is a top priority in the battle against untreatable infectious diseases. Peptidomimetics can successfully control infections caused by multidrug-resistant pathogens. This Perspective discusses fi ndings in a recent Science paper on a member of this class of therapeutic agents that targets bacterial outer-membrane synthesis.",
author = "Alessandra Bragonzi",
year = "2010",
doi = "10.1126/scitranslmed.3000889",
language = "English",
volume = "2",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "21",

}

TY - JOUR

T1 - Fighting back

T2 - Peptidomimetics as a new weapon in the battle against antibiotic resistance

AU - Bragonzi, Alessandra

PY - 2010

Y1 - 2010

N2 - The discovery, development, and clinical exploitation of antibiotics with new mechanisms of action is a top priority in the battle against untreatable infectious diseases. Peptidomimetics can successfully control infections caused by multidrug-resistant pathogens. This Perspective discusses fi ndings in a recent Science paper on a member of this class of therapeutic agents that targets bacterial outer-membrane synthesis.

AB - The discovery, development, and clinical exploitation of antibiotics with new mechanisms of action is a top priority in the battle against untreatable infectious diseases. Peptidomimetics can successfully control infections caused by multidrug-resistant pathogens. This Perspective discusses fi ndings in a recent Science paper on a member of this class of therapeutic agents that targets bacterial outer-membrane synthesis.

UR - http://www.scopus.com/inward/record.url?scp=77953017278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953017278&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3000889

DO - 10.1126/scitranslmed.3000889

M3 - Article

VL - 2

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 21

ER -